CARMENA in mRCC and Surgical Management Cases in Bladder Cancer from ASCO 2018 - Tom Keane

(Length of Discussion: 30 min)

Tom Keane, MBBCh, FRCSI, FACS provides a detailed overview of the CARMENA study, presented by Arnaud Mejean MD, Ph.D. at ASCO 2018.  This Phase III randomized trial assessed the utility and timing of CNx in the treatment paradigm of mRCC comparing patients who were randomized to either CNx and sunitinib vs sunitinib alone without CNx.  He discusses the clinical application of the findings of CARMENA as well as comparing the results with that of another study, SURTIME, an EROTC presented at EUA 2018.

Next, Tom Keane reviews Dr. Gary Sternberg’s ASCO 2018 presentation of Nuances of Surgical Management of Localized/Locally Advanced Urothelial Cancer. In this multi-disciplinary session focused on bladder cancer, 3 specific patient cases were addressed.  He begins with an overview of the initial patient presentation and moves through each case highlighting the surgical management options for each. 


Thomas E. Keane, MBBCh, FRCSI, FACS

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.